A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors

Abroad (travel likely)RecruitingPHASE1

Conditions

Ovarian Cancer · Melanoma · Triple Negative Breast Cancer · Colorectal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

NEXT Oncology, Dallas, Dallas, Texas, United States
Contact: Study coordinator (Erica Torres) · etorres@nextoncology.com · 737-610-5205
Next Oncology, Virginia Cancer Specialists, Fairfax, Virginia, United States
Contact: Study coordinator (Blake Patterson) · bpatterson@nextoncology.com · 703-783-4505

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of NX-1607 in Adults With Advanced Malignancies

Ovarian Cancer, Epithelial · Gastric Cancer · GastroEsophageal Junction (GEJ) Cancer

Abroad (travel likely)RecruitingPHASE1

Duarte, United States · Los Angeles, United States

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

Refractory Cancer · Recurrent Cancer · Solid Tumor, Adult

Abroad (travel likely)RecruitingPHASE1, PHASE2

Stanford, United States · Aurora, United States

Ovarian Tissue Cryopreservation for Fertility Preservation

Cancer · Autoimmune Diseases

Abroad (travel likely)Recruiting

Pittsburgh, United States

Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment

Cancer

Abroad (travel likely)Recruiting

Los Angeles, United States